Presenter: G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
0:00
In episode 485, Mike and James go over a couple of COVID trials that show two different anti-inflammatories – colchicine and inhaled budesonide – seem to have an effect on reducing hospitalizations or urgent care visits. 1) Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial Lancet…

November 18, 2021
Presenter(s):
G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
Very important information